Quotient Investors’s Charles River Laboratories CRL Stock Holding History

Quotient Investors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,638	Closed	-$231K	–	224
2015 Q3	$231K	Sell	3,638 -1,462	-29%	-$105K	0.05%	182
2015 Q2	$359K	Buy	5,100 +2,200	+76%	+$163K	0.05%	191
2015 Q1	$230K	Sell	2,900 -3,500	-55%	-$258K	0.03%	214
2014 Q4	$407K	Sell	6,400 -3,100	-33%	-$194K	0.08%	184
2014 Q3	$568K	Sell	9,500 -16,300	-63%	-$933K	0.12%	149
2014 Q2	$1.38M	Sell	25,800 -6,900	-21%	-$379K	0.3%	108
2014 Q1	$1.97M	Buy	32,700 +9,400	+40%	+$548K	0.45%	73
2013 Q4	$1.24M	Hold	23,300	–	–	0.29%	112
2013 Q3	$1.08M	Sell	23,300 -2,500	-10%	-$115K	0.28%	126
2013 Q2	$1.06M	Buy	+25,800	New	+$1.11M	0.3%	115

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Quotient Investors's CRL Position: Q4 2015 in Review

Quotient Investors sold out of Charles River Laboratories (CRL) in Q4 2015, closing a stake of 3,638 shares — an estimated $231K sold.

Quotient Investors first reported a position in CRL in Q2 2013 and held it in 10 quarters. The position peaked at $1.97M in Q1 2014. 268 funds tracked by Wall St. Rank hold CRL as of Q4 2015.

Quotient Investors reported no remaining Charles River Laboratories position as of Q4 2015 after selling out during the quarter.
Quotient Investors sold 3,638 Charles River Laboratories shares in Q4 2015, an estimated $231K.
Quotient Investors first reported a position in Charles River Laboratories in Q2 2013 and held it in 10 quarters.
Quotient Investors's Charles River Laboratories position peaked at $1.97M in Q1 2014.
268 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2015.

Based on Quotient Investors's 13F filing for Q4 2015, filed 14 Jan 2016.